Citigroup Initiates Coverage On Sana Biotechnology with Buy Rating, Announces Price Target of $8
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Samantha Semenkow has initiated coverage on Sana Biotechnology (NASDAQ:SANA) with a Buy rating and a price target of $8.
September 05, 2023 | 10:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup has initiated coverage on Sana Biotechnology with a Buy rating and a price target of $8.
The Buy rating and price target set by Citigroup indicates a positive outlook for Sana Biotechnology. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100